A landmark study has found that cannabidiol (CBD) doesn’t trigger driver impairment when taken in small doses while the impairment caused by THC fizzles out in just a matter of hours.
The researchers based at Sydney University in Australia concluded that when drivers consume small amounts of THC, which trigger intoxication similar to that experienced by an individual who takes alcohol resulting in a 0.05 percent blood alcohol level, the impairment of their driving competence faded within four hours after consumed the dose of marijuana.
This study comes at a time when many people are concerned about the likely effects of the increasing legalization of cannabis, either for medicinal or recreational purposes.
For example, opponents of legalization keep insisting that cases of cannabis-impaired driving will increase, but the lack of concrete evidence to that effect waters down their arguments.
Similarly, medical cannabis patients constantly worry that they could be prosecuted for impaired driving days after they consumed their medicine if metabolites are detected in their blood during a roadside test.
The Sydney research helps to reassure all concerned, especially those users the substance, that they are unlikely to endanger anyone on the road as long as wait several hours after consuming the small dose of THC-rich medical marijuana.
To quantify the impact of cannabinoids upon drivers, the scientists divided the study participants into four groups. Each group was then requested to vaporize a different cannabis blend. One blend mainly had THC, another contained mainly cannabidiol, a third product was composed of a mix of those two cannabinoids, while the fourth product was a placebo with hardly any cannabinoids.
For all blends having the two main cannabinoids being studied, the concentration was capped at 13.75 mg.
All participants then had to drive (twice) 100 km on a highway in the Netherlands. The first drive was initiated 40 minutes after the participants had vaporized the blend, while the second round of driving took place four hours later. Each driver had a licensed instructor observing them throughout the trip.
A barrage of data was collected from the drivers in a laboratory. For example, the concentration of cannabinoids in their blood was measured, as was their cognitive performance. During the driving test, each participant was observed to see the extent to which their vehicle drifted outside their specific assigned lane. This is a common metric used to track impaired driving.
The study indicates that for the drivers who had taken the small dose of CBD, no signs of impairment were detected during either of the driving tests. However, individuals who consumed the product containing THC exhibited mild levels of impairment similar to what would be seen in a person whose blood alcohol level was 0.05%.
Four hours later, the THC group of study participants didn’t exhibit any sign of impairment, and their blood tests showed that the cannabinoid had tapered off.
It is interesting to observe that the researchers noticed that, unlike what happens when people take impairment-inducing amounts of alcohol, those who took THC appeared to be aware of their diminished driving abilities as they revealed that they felt less confident while taking to the wheel.
This study is one of the first to provide verifiable data about the impact of small doses of CBD and THC on drivers but shouldn’t be relied upon to indicate what could happen when bigger doses of these compounds are consumed.
Many companies have come up to make a variety of cannabis products, and those companies are thriving. One of the notable firms in this regard is The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER). Its innovative electrolysis process has helped the company establish a strong reputation for its bottled and perfectly balanced alkaline water, as well as its CBD-infused products.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
Monday, December 7th, 2020UncategorizedComments Off on $WTER 420 with CNW – Groundbreaking Study Finds CBD Doesn’t Cause Driver Impairment While THC’s Impact Fades Quickly
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its president and CEO, Richard Wright, is scheduled to present in two virtual investor conferences during December 2020. According to the update, Wright will participate in various one-on-one meetings with institutional investors during the Roth Virtual Deer Valley Consumer Event on Dec. 10-11, 2020. In addition, Wright will be presenting to a panel of industry experts at 11:20 a.m. Eastern Time on Monday, Dec. 14, 2020, at the LD Micro 13th Annual Main Event. The events will be webcast live (where available), and an updated presentation will be available in the Investor Relations section of The Alkaline Water Company’s website.
Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp, powder packs, oil tinctures, capsules and gummies. To learn more about the company, visit www.A88CBD.com and www.TheAlkalineWaterCo.com.
NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
SRAX Inc.’s (NASDAQ: SRAX) Sequire Software Helps Public Companies Gain Clarity Amid “Gut-Wrenching” Stock Market Volatility
COVID-19, the election, and preference shift towards growth-oriented stocks causing unprecedented stock market volatility
SRAX’s Sequire SaaS platform unlocks big data investor insights for public companies
Sequire’s user base grown to over one million investors, traders across 125 companies and partners
Sequire’s Q3 2020 performance includes over $6.7 million in bookings and 37% increase in subscriptions
The stock market is currently going through a phase of unprecedented volatility caused primarily by political and societal issues, projected to continue well into 2021. As a proactive response, some public companies are choosing to gain clarity about their investor activity through Sequire, a SaaS platform created by SRAX (NASDAQ: SRAX) that unlocks data and insights through warrant tracking, survey creation, events, roadshows and customer relationship/resource management (“CRM”).
According to a recent BTIG report (https://ibn.fm/QXqZ0), issues with COVID-19, the United States presidential election and a general market shift towards growth-oriented stocks are the three major transitory events causing extreme volatility in the markets.
“We’re living through three transitions which, in a period of elevated volatility, are reminders that the path to the long term is a series of short terms — often gut-wrenching, both down and up,” wrote strategists Julian Emanuel and Michael Chu in the BTIG report.
Among other factors connected to the economic downturn, volatile market conditions have added to the toll taken on public companies. Besides poor performance across almost every industry, the situation has been made more challenging by extra pressure from stakeholders on management to keep driving share prices upward.
To that end, Sequire has the potential to add significant value to marketing efforts by unlocking the power of data, engaging current investors and attracting new capital through marketing campaigns. Since its creation in 2019, the platform’s user base has grown rapidly to over one million investors and traders across 125 companies and partners.
Accordingly, Sequire’s performance in Q3 2020 was stellar with over $6.7 million in bookings, its first positive quarter EBITDA, and a 37% increase in subscriptions. SRAX’s overall performance is in line with the success of the platform, with 161% year-over-year and 124% quarter-over-quarter revenue growth.
“As the Sequire platform continues to grow and adapt to customer needs, we are seeing a tremendous increase in our recurring revenue stream,” said SRAX Founder and CEO Chris Miglino. “Sequire is changing the way public issuers interact with and engage their investors, and it shows. We are pleased to report our first quarter of positive EBITDA from our Sequire segment” (https://ibn.fm/buUFN).
SRAX is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its premier investor intelligence and communications platform. Through Sequire, companies can track investor behaviors and identify trends for use in campaigns to engage current and potential investors across marketing channels.
For more information, visit the company’s website at www.SRAX.com
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Wordson all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Monday, December 7th, 2020UncategorizedComments Off on $SRAX Sequire Software Helps Public Companies Gain Clarity Amid “Gut-Wrenching” Stock Market Volatility
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through Sequire, today announced that Shaquille O’Neal and Brock Pierce will be the keynote speakers at the 13th Annual LD Micro Main Event, a prominent 2-day virtual investor conference. The event will be held via SRAX’s Sequire Virtual Events platform on Dec. 14 – 15, 2020. Nearly two million active small-cap investors have been invited to the event, which will feature interesting celebrity keynotes and close to 250 presenting companies in a brand new format. Interested parties should visit https://ibn.fm/H8G9W to register and access further details regarding the event.
SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com and MySequire.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Australia hasn’t made a lot of progress towards electrifying its roads. While countries such as the UK, France and Germany have set clear targets for banning the sale of new internal combustion engine (“ICE”) vehicles, Australia’s climate politics has been described by some as “broken.” The country currently has a paltry 20,000 electric vehicles on the road, and only 0.6% of new cars sold in the country are electric.
Now the state of Victoria is planning to introduce a road user tax for electric vehicles (“EVs”) that has the potential to cripple the EV industry before it even takes off. The Victorian government wants to impose a charge of 2.5c a kilometer on electric vehicles and 2c/km on hybrid plug-in cars. The argument is that folk who drive ICE vehicles pay for the roads through a national excise on fuel, a charge EV drivers do not have to pay. According to a government spokesman, the tax will make sure that all Victorian motorists pay their fair share.
However, critics of the proposed tax say that it could jeopardize the adoption of electric vehicles in the country. Federal government modelling, based on current policies, had posited that electric vehicles would make up 65% of new vehicles sold by 2050, says Dr. Lake Whitehead from the University of Queensland’s Dow Center for Sustainable Engineering Innovation. His analysis found that if the 2.5c tax rate were imposed without any incentives, EVs would make only 40% of new vehicle sales by 2050.
This equates to at least 4.9 million fewer electric vehicles sold. As the amount of cars on the roads are forecast to increase significantly, having a reduced number of zero-emission electric vehicles will likely lead to increased greenhouse emissions. Without additional measures such as reducing or altogether removing stamp duty, registration costs and road tolls, Whitehead says, electric vehicles will be too pricey for most drivers to switch.
His analysis found that the 2.5c/km tax would be equivalent to a $4,500 bump in the vehicle’s initial purchase price while a $5 congestion tax usually charged in inner-city areas capped at $15 a day would add $2,800 to the price. He concludes that the proposed EV tax is “completely incongruent” and does not line up with the state’s target of achieving net-zero emissions by 2050. Although a road user tax does make sense, it would only work for the EV industry if it was accompanied by incentives that made EVs more affordable.
Elsewhere, the electric vehicle sector is seeing rapid transformations. For example, Net Element (NASDAQ: NETE), a global fintech firm that supports the making and receiving of electronic payments, is set to merge with EV maker Mullen Technologies Inc.
NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
NETE results include year-over-year increases in revenue and transaction volume
45% of NETE clients in restaurant business, management expects rebound once states reopen
NETE plans to divest payments processing model to enter EV industry through reverse-merger with privately-held Mullen Technologies Inc.
Net Element (NASDAQ: NETE), a global financial technology and payments processing company, recently posted its Q3 2020 results showing improved revenues despite continued shutdowns in NY and California. The value-added solutions group supports electronic payments acceptance in an omni-channel environment that spans point-of-sale, e-commerce applications and mobile devices for small to medium enterprises in the U.S. and selected emerging markets.
Business closures due to COVID-19 have affected NETE revenues negatively, particularly for the restaurant industry that comprises approximately 45% of its customer base. With most of the business coming from the southern states, NETE management believes that card processing volumes for the company could rebound sharply if their customers in New York and California could open up again.
Despite the negative outlook and overall sinking economy, company revenues improved in Q3 2020, coming in at $16.7 million from $13.7 million in Q2 2020 (https://ibn.fm/S1d2d). Other highlights from their Q3 results include a year-over-year increase in total transaction volume from $956.2 million to $953.7 million and a year-over-year increase in their North American Transaction Solutions segment to $16.07 million from $15.9 million (https://ibn.fm/od2oj).
The company reported a net loss to common stockholders of approximately $0.52 per share or a total net loss of $2.3 million – almost twice the $1.0 million net loss or $0.24 per share loss for the same period in 2019. The $1.3 million net loss increase is primarily attributed to an increase in non-cash compensation of approximately $1.1 million and an increase in bad debt expense amounting to approximately $200,000.
Gross margin for the quarter was $2.2 million or 13.0% of net revenues, down from $2.7 million or 16.3% for the same period in 2019, attributed to the increased competitive pressure in the industry. Year-over-year operating expenses increased to $4.1 million from $3.6 million while salaries, benefits, taxes and contractor payments decreased by approximately $0.4 million due to staffing reductions connected to COVID-19.
Earlier this year, NETE announced plans to divest itself of its payments processing services in order to enter the electric vehicle industry through a reverse merger with Mullen Technologies. Following the requisite approvals, the transaction will allow the stakeholders of privately-held Mullen to gain a majority of the new stock while accelerating the process of taking the new company public. NETE continues to work diligently on the transaction while Mullen completes its audit and S-4 document with expectations to have it filed by the end of the year.
“We continue working diligently in an effort to finalize the Mullen merger for the benefit of our shareholders,” said Net Element Executive Chairman Oleg Firer.
Formerly ranked as one of North America’s fastest growing companies on Deloitte’s Technology Fast 500(TM) in 2017 and 2018, NETE offers 100-plus payment solutions in an omni-channel environment for small to medium enterprises. Following the approval of its reverse merger with California-based Mullen Technologies, the company plans to divest its payments-as-a-service business model and enter the electric vehicle industry.
For more information, visit the company’s website at www.NetElement.com.
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
The multibillion-dollar natural resources industry in Utah is thriving, with copper being the most valuable metal extracted in the industry. The Utah Geological Survey (UGS) recently released a report on the state’s mining activities in the last year. Last year’s figures indicate a growth of 2.4%, which equates to more than $90 million. The most valuable metal mineral of the state is copper while the total value with regard to extractive resources, inclusive of gas and oil, is approximated at $6.5 billion. Mining takes up a huge chunk of this value — 60% of it — bringing the value of minerals mined to $3.9 billion.
Michael Vanden Berg, a senior scientist at UGS, stated that the natural resource industry was a strong contributor to the state’s economy in terms of tax revenue and supplying the materials required to develop and support the society. The industry, he noted, also creates jobs for many individuals, especially in rural communities.
The aforementioned report sums up the 2019 values and mineral resource output data for Utah’s mining industry. The report includes unconventional fuel and industrial minerals data as well as data on nonfuel mineral resources, counting precious and base metals, uranium and coal. The report also offers updates on various exploration projects.
In the report, readers learn that Utah was among the top states in the production of industrial minerals and metals last year. Under industrial mineral products, brine was found to be the most valuable, accounting for $483 million with regard to the state’s mining value. Utah’s most precious metal — copper — was valued at $1.2 billion. Comprehensively, metals made up $2.1 billion of the state’s mining value with industrial minerals making up $1.3 billion. In addition to this, the coal market brought in $480 million.
The state is still the only beryllium generator in the country. Its total output of 2019 made up roughly 65% of the total beryllium produced globally. Beryllium is a tough and light metal that has various applications in telecommunications, computer, medical, automobile, aerospace and defense.
Last year, extractive industries in Utah, inclusive of gas and oil, paid federal mineral lease disbursements of roughly $80 million. The coal, gravel and sand, industrial mineral, and metal mining industries in the state also paid property taxes of more than $82 million. Severance taxes related to mining of about $13 million were also paid for by the industry.
Mining employment was cited as stable with employment at coal mines growing from 1,185 workers to 1,397 workers as of 2019.
Outside Utah, the U.S. mining sector has many success stories for the world. A case in point is Energy Fuels Inc. (TSX: EFR) (NYSE American: UUUU), a Colorado-based firm that has surpassed all others across the country with regard to the production of two critical minerals: uranium and vanadium.
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
President Vladimir Putin of Russia has ordered that health officials in the country begin coronavirus vaccinations next week. The country has manufactured about 2 million doses of its vaccine.
President Putin’s statement was made on the same day that Britain gave its seal of approval for the BioNTech-Pfizer vaccine to be made available to the public, also starting next week. In the previous week, the country produced provisional test results of the Sputnik V vaccine that showed that it was more than 95% effective. The vaccine was developed by the National Research Center for Epidemiology and Microbiology.
The vaccine is currently in the phase 3 clinical trial. This is the final stage of testing and has involved around 40,000 volunteers. The vaccine was named after a satellite from the Soviet era. Putin urged health officials to arrange for widespread vaccinations that would ensure that by the end of the coming week, the country would have already begun extensive vaccination. He added that medics and teachers would be the first to be vaccinated, with an additional 2 million vaccine doses or more being manufactured in the days to come.
The Sputnik V vaccine is given in two doses, with the second dose being administered after 21 days. The jab uses two human adenovirus vectors and will be administered voluntarily to individuals. Additionally, the jab will be free for all citizens of the country.
The defense ministry of Russia had previously announced that a widespread campaign to vaccinate service personnel in the army had begun. The objective is to vaccinate more than 400,000 military personnel, aiming to have inoculated at least 80,000 soldiers by the end of 2020.
Mikhail Murashko, Minister of Health in Russia, stated during a UN video link that more than 100,000 individuals had already been inoculated with the Sputnik V vaccine. The video link was centered on vaccine presentation. The head of the Russian Direct Investment Fund, Kirill Dmitriyev, who was involved in vaccine development, spoke at the same conference, stating that above 40 nations had expressed interest in the Sputnik V vaccine. In addition to this, he said, orders totaling more than 1.2 billion vaccine doses had been made.
Currently, Russia has among the highest cases of the coronavirus globally, with 41,053 casualties and 2,347,401 cases. Last week, health officials reported 25,345 new cases and 589 fatalities. To help contain the virus, authorities plan to close restaurants, concert halls, theatres, museums and bars in St. Petersburg starting Dec. 31.
The novel coronavirus isn’t the only health challenge for which biomedical companies have been working to find solutions. Other challenges, such as chronic diseases, have also received their fair share of attention. For instance, Israel- and New York-based DarioHealth Corp. (NASDAQ: DRIO) has been helping chronic disease patients to make beneficial lifestyle changes using DarioHealth’s smartphone-based software.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced approval by its board of directors to begin the process of uplisting to major North American stock exchanges. According to the update, Loop plans to apply to have its common shares uplisted to the Toronto Stock Exchange (“TSX”), as a technology company, from the TSX Venture Exchange (“TSXV”), subject to meeting certain conditions and the approval of the TSX. Additionally, if successful in uplisting to the TSX, Loop intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States (the “SEC”), which will enable Loop to apply to be listed on the NASDAQ. “As a result of our immutable relevancy, high demand for Loop’s products, pipeline growth, and ability to easily scale into a global marketplace that is in full press digital transformation, we expect a continued accelerated pace that now warrants an uplist and dual list strategy that will attract institutional investors commensurate with our anticipated profile in 2021 and far beyond,” said Loop Insights CEO Rob Anson.
Loop Insights is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network. For more information, visit the company’s website at www.LoopInsights.ai.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Recent data on cannabis sales in the state of California shows that sales have been doing well despite the pandemic situation. The California Legislative Analyst’s Office (LAO) released a report this week noting that sales figures recorded during summer and revised numbers from 2019 show that the market has grown. This trend has also been observed in various states that have legalized marijuana such as Oregon and Illinois.
LAO estimates that the state of California gathered nearly $41 million of cannabis cultivation fees and $160 million in cannabis tax revenue in the July–September quarter of the 2020/2021 fiscal year. The revised numbers from the 2019/2020 fiscal year with regard to marijuana tax dollars shifted from $477 million to $522 million.
The LAO stated that the marijuana tax revenues grew expeditiously in both 2019 and 2018, adding that this growth had sped up this year in the middle of the coronavirus outbreak.
Data released one week earlier by the state’s Department of Tax and Fee Administration indicates that the state of California is on course to rake in $1 billion in marijuana tax revenue this year. In the first three quarters of 2020, the total sum collected with regard to cannabis taxes adds up to $778.4 million. This figure is inclusive of revenue generated in the third quarter, which totaled $306.8 million.
The revenue collected from the cannabis market will be used to fund a grant program whose aim is to bolster public health and economic justice for communities that have been unreasonably affected by the drug war. Grant applications were made accessible in September.
In Illinois, similar and consecutive growth in cannabis sales have been recorded amid the coronavirus pandemic, generating record-breaking revenue. The state of Illinois reported last month that in October, adult consumers of cannabis bought more than 1,500,000 marijuana products, whose total value was $75,278,200. This indicates an $8 million growth in sales when compared to sales figures from September.
Last month, regulators in Massachusetts reported that marijuana sales in the state had grossed more than $1 billion since adult-use sales began not more than two years ago. In another report released by Oregon officials, monthly marijuana sales in that state have brought in about $100 million on average this year.
These surges in cannabis sales have benefited numerous cannabis companies, such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), which earlier this year launched its A88CBD™ brand featuring a broad line of CBD topical and ingestible products.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
How Will These Penny Stocks Perform in December 2020?
With November behind us at this point, December is a new month ripe with potential for penny stocks . While not all penny stocks hold high value, with careful research, we can find the ones that are. One of the best pieces of advice that pro-investors give is to make sure that one has all the information they can about a given penny stock.
While this may not seem too important, it is the best way to avoid surprises in one’s portfolio. With information at hand, investors can often make educated guesses as to what could happen with price action regarding a given penny stock. This is not to say that we can completely avoid volatility, but rather that information can often protect our investments.
The second thing for penny stock investors to consider is what area of the stock market they wish to invest in. Right now, covid is the biggest factor for the entire stock market, providing both positive and negative momentum. Within the stock market, several industries with correlations to covid, have seen positive momentum in the past month or so.
This includes biotech stocks, EV penny stocks , digital communication stocks, and others. With these categories in mind, investors can begin to create a list of penny stocks to watch. All things considered, here are four companies that could be worth watching right now. But are they the best penny stocks to buy right now?
Penny Stocks to Buy [or avoid]: Foresight Autonomous Holdings ADR
Foresight Autonomous Holdings ADR is another one of the leaders in terms of gains on December 3rd. During the trading day and into after hours, shares of FRSX stock shot up by around 24%. On December 3rd, the company announced that it will be exhibiting a mass covid-19 symptom detection solution at the GITEX Future star 2020 conference.
This is a big deal as it could put FRSX stock in the covid penny stocks to watch category. The company primarily works as a technology company that designs, develops, and commercializes sensors for the automotive industry. This includes the autonomous vehicle market as well as software for connecting vehicles to the IoT world.
Additionally, on November 12th, the company reported its Q3 2020 financial results for the period ending on September 30th. In the results, the company ended the quarter with around $14.5 million in cash. Haim Siboni, CEO of the company, stated that “Foresight continued to demonstrate steady progress in the third quarter, as we established new partnerships with influential players in Europe, Japan, and China. We are confident that our new relationships with leading companies…will lead to stable sales growth.”
Penny Stocks to Buy [or avoid]: OrganiGram Holdings Inc.
OrganiGram Holdings Inc. is one of the largest producers of cannabis in the industry. On December 3rd, shares of OGI stock shot up by around 7% during intraday trading. In the past five days, shares of the company are up by as much as 23%. One of the main issues that we have seen in the past with Canadian cannabis producers was the oversupply of marijuana to the industry.
While these companies were dealing with this issue, U.S. cannabis companies were able to gain the top spot. In the past few months, however, many Canadian marijuana stocks have been able to climb in value as oversupply is no longer an issue. Recently, OrganiGram reported its Q4 2020 financial results.
In the results, net revenue shot up by a solid 25% to $20.4 million. In terms of gross revenue, OrganiGram brought in around $25 million which is a 32% increase over Q4 2019. Greg Engel, CEO of OrganiGram stated that “we are excited about OrganiGram’s prospects as we continue to reinvigorate and diversify our product portfolio with new offerings aimed at delivering the attributes that matter most to consumers. Overall, we are very encouraged by the initial responses to our new products and the increased awareness and ration they are receiving against a backdrop of national retail store growth and a growing legal market.”
With all of this in mind, investors can decide if OGI stock is a marijuana penny stock to watch or not.
Penny Stocks to Buy [or avoid]: Advaxis Inc.
Advaxis Inc. is another big gainer for December 3rd, pulling in around 8% in gains by EOD. Since last Friday, shares of ADXS stock have shot up by almost 23%. For some context, Advaxis is a clinical-stage biotech company working on the development and commercialization of several immunotherapy products.
The company utilizes what is known as live attenuated Listeria monocytogenes, which can secrete antigen-proteins. While this may sound complicated, this simply means that it is utilizing organic compounds to produce an immune response from the body. Recently, the company announced that it has closed on an underwritten public offering of around 26.6 million shares of common stock.
The company states that it should bring in around $9.2 million in gross proceeds for the company. With these funds, Advaxis should be able to move forward with R&D regarding its ADXS-HOT program as well as for general corporate funding. As a biotech company, Advaxis has received a great amount of popularity during the Covid pandemic.
While it isn’t truly a covid penny stock by most definition, it still has a high correlation to other stocks that are more involved in the covid industry. While it is a volatile biotech penny stock, the company does have a lot going for it moving into the end of the year.
Penny Stocks to Buy [or avoid]: Sigma Labs Inc.
Sigma Labs Inc. is a provider of software to the 3D metal printing industry. The company works with its program known as PrintRite3D to aid in the production of advanced manufacturing techniques. The company states that its product can detect defects in a 3D print in real-time. This is a game-changer for the 3D printing industry as it allows for less waste and better time management.
The company states that its products can help bring to fruition a widespread use of metal 3D printing. On December 3rd, shares of SGLB stock shot up by around 4% during the trading day. This occurred before shooting up another 24% during after hours. In addition, the company recently reported its Q3 financial and operating results for the period ending on September 30th.
In the results, Mark Ruport, CEO of the company stated that “the third quarter of 2020 was about execution and laying the foundation for a successful 2021 and we are very pleased to have made significant progress in each of the strategic initiatives that we established at the beginning of the year. On the financial front, our balance sheet expanded during the third quarter by $3.5 million…During the third quarter of 2020, we announced a contract with a major oil and gas services company, following a successful Rapid Test and Evaluation program.”
Because it is a cutting edge company, Sigma Labs has only a small amount of competitors to worry about. With this in mind, investors could consider it to be a penny stock to watch moving forward.
Penny Stocks To Buy [or avoid]: Cinedigm
If there’s one hot corner of the market gaining steam it’s streaming technology. We’ve seen companies like Fubo (FUBO Stock Report) rally explosively on new advancements with their platform. In-kind, Cinedigm has also gained ground after its own key update on Friday. The company announced more linear streaming channels on its platform. These were launched on the Rad streaming service. The launch puts numerous entertainment channels on platforms like Playstation 5, Android TVs, and Android mobile devices.
This essentially puts the content in front of millions of users. Considering that this comes amid the holiday season, it could be well-timed for CIDM. During the premarket session on Friday, shares traded much higher following this news. The biggest point of focus right now should be on the technical side of things.
For months, CIDM stock had a tough time breaking above major moving averages. The most recent has been its 50-day moving average sitting around 55 cents. While the stock managed to break above this level during the premarket hours, traders will likely be watching closely to see if this can hold.
Friday, December 4th, 2020UncategorizedComments Off on $SGLB Are These 4 Penny Stocks To Buy Now Or Should You Wait?
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced that its proposed acquisition partner Cannaworx Inc. has set December 2020 as the commercial launch date for its patented immune booster supplement: ImmunaZin(TM). According to the update, Cannaworx believes that post-launch, this product will be one of very few over-the-counter, FDA-registered, hemp seed oil-enhanced supplements with an immune-booster claim. “Our team is excited to be joining a company bringing such an important and valuable product to market, particularly considering its potential role in the fight against the novel coronavirus and other disease-causing pathogens,” said Richard T. Schumacher, president and CEO of Pressure BioSciences. “We also look forward to bringing our proprietary Ultra-Shear Technology(TM) (‘UST(TM)’) platform for the processing of high quality nanoemulsions with vanishingly low and controlled droplet sizes, to bear on the emerging compendium of Cannaworx personal care products rolling out in late 2020 and throughout all of 2021.”
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling pressure-based solutions for the worldwide life sciences and other industries. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Pressure BioSciences’ primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday provided an update on three portfolio companies: TerrAscend, YSS and Dynaleo. “Over the past month, our portfolio companies have made several announcements that demonstrate their continued momentum and growth in their respective markets,” said Canopy Rivers’ Narbe Alexandrian. “We believe that this growth is a testament to the theses behind these investments, and we look forward to seeing their progress continue into 2021.”
Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. The company believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging industry insights, in-house expertise and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders exposure to specialized and disruptive cannabis companies. Canopy Rivers’ mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, the company is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.
NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
The National Institutes of Health extended the COBRE grant valued at over $11 million for the University of Delaware biomedical research team. This will allow the team to proceed to phase 2 of their research.
The Center of Biomedical Research Excellence grant is centered on finding therapeutic leads and chemical probes. The research team is led by Professor Joseph Fox, a professor in the Department of Engineering and Materials Science as well as the Department of Biochemistry and Chemistry. The team of researchers who were awarded the grant are focused on discovering new molecules that can be utilized in studying and treating diseases such as Legionnaires disease, tuberculosis, Crohn’s disease, renal cancer and breast cancer.
University of Delaware President Dennis Assanis stated that interdisciplinary partnerships were a feature of the university’s research and that the grant renewal served as recognition for the successful achievements of the group of biomedical researchers and Fox, their leader. He added that the work the team did would further new therapy development for treating various ailments that have affected many individuals. He finished by congratulating the team and adding that he looked forward to the strides the team made. This team of researchers is based at the Science, Technology and Advanced Research Campus in the University of Delaware.
University vice president for innovation, scholarship and research Charles G. Riordan said that various aspects of the University’s program unite the community of vital researchers who work to discover of new therapies as well as drug development.
As the team proceeds to phase 2, more researchers have joined the group, including Karl Schmitz and Ramona Neunuebel from the University’s biological sciences department, Juan Perilla and Jeff Mugridge from the biochemistry and chemistry departments ,and Catherine Fromen from the biomolecular and chemical engineering department.
Phase 1 of the grant had given rise to many advances, leading to the development of techniques that are currently being used in drug discovery by research groups and pharmaceutical firms across the globe.
Fox, lead in the COBRE grant, mentioned that the grant renewal would help to further broaden the capabilities of the center, including by developing a proteomics core that would enable synthetic chemistry. In addition, the grant would support two vital facilities: the Synthesis and Discovery Core Facility and the Analytical Chemistry Core Facility. The two facilities support various instruments that include microscopy, small-molecule synthesis, catalyst discovery as well as mass spectrometry and nuclear magnetic resonance.
Many biopharmaceutical companies are also conducting their own research to find solutions to the health challenges people face. An example is AzurRx BioPharma Inc. (NASDAQ: AZRX), which specializes in developing remedies to diseases that afflict the gastrointestinal tract.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
People who consume alcohol in the United States are often stopped on the roadsides and asked to take breathalyzer tests. If an individual’s blood alcohol content exceeds a specified limit, they may be subjected to penalties, fines and tickets; they could even be arrested. On the other hand, marijuana does not currently have an intoxication test, which makes it harder for authorities to determine individuals who may have exceeded the limit and are driving while impaired.
Researchers have, however, reported that they are on the verge of a breakthrough, developing a saliva test to help measure marijuana levels at roadside stops. The research findings collected by these scientists were presented on the SciMeetings platform that was held online by the American Chemical Society.
The study’s lead, Shalini Prasad, stated that while people think that driving while high on cannabis is safer than driving when intoxicated on liquor, both alcohol and cannabis have similar effects on individuals. This includes a decrease in self-awareness, a decline in a person’s alertness and a slowed reaction time. However, researchers have yet to determine a definite level of THC, the psychoactive compound found in cannabis, that can cause impairment. Preliminary reports suggest that between 1 to 15 THC nano grams per ml of blood may be considered as an impairment level.
With the number of states that are decriminalizing cannabis growing, law enforcement authorities are struggling to find ways to ensure that the roads remain safe from drivers who may be driving while intoxicated. While THC blood tests do exist, and they are invasive and laborious. In addition, most police officers do not have the skills required to administer these tests at roadside stops. Some scientists are working on tools to help measure levels of THC that are similar to alcohol breathalyzers. However, Prasad explains that THC levels in a person’s breath are low, and these devices may need extensive data processing to allow other compounds to be filtered out.
With the discovery that the THC found in saliva corresponds to the THC found in the blood, Prasad and colleagues have found a way around this. The University of Texas researchers have developed an electronic reader and sensor strips that pick up on any THC present in a sample. They have conducted a test using a drop of human saliva, which had been contaminated with THC. Their findings demonstrate that the device could test THC levels that range from 100pg/ml to 100 ng/ml accurately. Additionally, it took the device less than five minutes to produce results.
Prasad adds that this test may find other applications apart from use in law enforcement. The data produced by this device may also be used by regulatory groups and legislators to create laws that are effective.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
WTER set to expand across the entire spectrum of hospitality, foodservice markets through key partnerships with Dot Foods, IBA
Lucrative segments such as golf foodservice, fast casuals, and vending and micro markets rapidly growing amid coronavirus outbreak
The Alkaline Water Company offers lifestyle brands that are a perfect complement for consumers seeking healthier choices
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, has set out to expand into hospitality and foodservice space. To secure coverage at both ends of the spectrum — from large national to large regional accounts — the Alkaline Water Company has entered into agreements with two strategic partners: Dot Foods Inc., the largest U.S. food redistribution company, and the Independent Broker Alliance (IBA), a renowned professional alliance of 30 independent foodservice sales agencies.
With these two agreements in place, WTER targets the whole hospitality and foodservice ecosystem, which is a very large addressable market, where even small share gains will fuel rapid growth for the company (https://cnw.fm/juoH0). According to the agreement with Dot Foods, the largest food redistribution company in the United States, Dot Foods will offer the entire line of Alkaline88(r) and A88 Infused(TM), along with the line’s eco-friendly aluminum bottles, to its 4,300 customers nationwide (https://cnw.fm/WQKxl). DOTs will also offer A88’s flavored waters as a featured all-natural flavored product, replacing a leading competitive brand that purportedly did over a million cases per year in the DOTS ecosystem.
“Adding the largest foodservice redistributor, Dot Foods, to our growing list of channel partners is another milestone for the company,” said The Alkaline Water Company president and CEO Richard Wright. “Every year, Dot Foods sells millions of cases of beverages to its customers. This relationship will give us an entry into the hospitality industry, which we view as a significant opportunity for our growing lifestyle brands. There are over 600,000 restaurants and foodservice establishments that will now have access to our full line of products.”
After announcing the agreement with IBS Foodservice, Wright noted that WTER now has two formidable partnerships to help it gain share in the hospitality and foodservice channel. “IBA is a highly respected professional foodservice sales and marketing organization comprised of 30 successful agencies,” he said. “With deep, long-term market-by-market relationships, the IBA has stellar local expertise in a well-connected, collaborative, and nationally respected alliance of independent brokers.
“Between our two partners, we expect DOT Foods to provide access to large national accounts and IBA to help us penetrate the large regional accounts across the entire hospitality and foodservice ecosystem,” Wright continued. “These partners give us the scale and scope to drive our growing lifestyle brands in the sizeable on-premise market estimated at over $14 billion by Beverage Marketing Corporation. We expect our single-serves, including A88 Infused flavors, eco-friendly aluminum bottles, and A88CBD infused lemon-lime water to do exceptionally well in the channel.”
WTER’s flagship product, Alkaline88, meets the growing demand from health-conscious, on-the-go consumers across lucrative markets. This smooth-tasting, mineral-enhanced beverage can be grabbed at restaurants, hotels, airports, stadiums, hospitals, schools, colleges/universities, parks, golf courses, health and fitness clubs, coffee shops, etc. One of these exciting sub-segments is the more than 15,500 golf courses and 4,415 private clubs managed by 13 golf-management companies in the U.S. Penetration of this market alone is expected to generate new opportunities, while fast-casual venues and vending machines are seeing accelerated growth in the post-COVID era (https://cnw.fm/YPRXQ).
As a company committed to an aggressive growth strategy, The Alkaline Water Company’s offering focuses on national, multichannel mass-market expansion with its premium, single-serve line of A88 water products. WTER’s products feature a growing list of infused flavors and are offered in eco-friendly aluminum bottles — an ideal fit for this lucrative space where consumers seek healthier, eco-friendly alternatives.
NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
Recent guidelines introduced by the World Health Organization (WHO) on sedentary behavior and physical activity show that indulging in weekly physical activities can neutralize the health harms linked to prolonged sitting. These guidelines were reported in as special issue of “British Journal of Sports Medicine.” The article notes that all physical activity is good for a person’s health in the long term.
This is the first time that such recommendations have been made, which indicates that there’s growing evidence that connects a sedentary lifestyle to grave ill health and an increased risk of early death. Data that was released last week in the same issue demonstrated that grown-ups who spend most of their time seated can balance out these risks by increasing the physical activity they indulge in every day.
This research, which involved more than 44,000 individuals from four nations, required the participants to wear activity trackers. The research revealed that if the majority of the time in the day of a person was spent seated, this was associated with a significantly increased risk of death, especially for individuals who were not physically active.
Do not despair, however. The research findings show that 30 to 40 minutes of physical activity, whether vigorous or moderate, considerably reduced this risk. This brought the risk levels down to those linked to low sedentary time. This confirms the guidelines that were cited in the 2020 WHO Universal Guidelines on Sedentary Behavior and Physical Activity.
The guidelines add that while there may not be enough evidence to help in suggesting specified thresholds for a stationary lifestyle, everybody should try to engage in physical activity. This will help reduce their everyday sedentary time. There’s no prescribed physical activity to partake in, as all physical activities count. This may include participating in a team sport, riding a bike, going for a jog, doing your household chores, gardening, walking or even choosing to take the stairs instead of the elevator.
WHO guidelines advocate for spending no less than 75 minutes every week partaking in activities of vigorous intensity or between two to five hours taking part in activities of moderate intensity. It should be noted that it is significantly better for your health to engage in any physical activity as opposed to none at all.
The guidelines explain that any individual who is unable to meet the aforementioned recommendations should start small and slowly grow the duration, intensity and frequency of their physical activity at a steady pace. Additionally, the guidelines highlight the importance of partaking in muscle strengthening and aerobic activities.
Many biomedical companies are engaged in finding solutions to the health-care needs of communities. One such company is Processa Pharmaceuticals Inc. (NASDAQ: PCSA). Among other interests, Processa acquires drugs for which clinical evidence of effectiveness exists, and then the company completes the regulatory requirements needed to gain approval for the drug.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Thursday, December 3rd, 2020UncategorizedComments Off on $PCSA Risks Associated with Prolonged Sitting Can Be Counteracted by Engaging in Physical Activity
Electric vehicles (“EVs”) are poised to take over the roads over the next two decades. As the effects of human-induced climate change have become more apparent, several governments have revealed plans to replace internal-combustion engine vehicles with zero-emission battery electric vehicles. For the longest time, plug-in hybrid cars (“PHEVs”) were thought to be the gap between conventional vehicles and EVs.
Powered by both an internal combustion engine and an electric motor coupled with a rechargeable battery, these vehicles would allow consumers to gradually switch to zero-emission vehicles. However, it has recently come to light that PHEVs may not be as environmentally friendly as previously thought. According to research done by the European group Transport and Environment (T&E) and backed by Greenpeace UK, a plug-in hybrid electric vehicle produces around 117g of CO2 for each kilometer travelled. This is considerably higher than the 44g of CO2 shown by official tests.
As such, the group has advised governments to end subsidies and tax breaks for PHEVs, which T&E senior director for clean vehicles Julia Polisanova calls “fake electric cars.” She has called for governments to stop subsidizing PHEVs with billions of taxpayers’ dollars, stating that hybrids are built for laboratory tests and tax breaks, not actual emission-free driving. The emission tests were carried out by Emissions Analytics using three plug-in hybrid SUV models: Mitsubishi’s Outlander, BMW’s X5 and Volvo’s XC60.
The announcement by T&E comes days after the European Union released proposed rules on emission limits that would strip plug-in hybrid cars of their green label beginning in 2026. Usually referred to as a gateway technology, PHEVs are a sort of kiddie pool for electric vehicles. Drivers first get the lay of the land in regards to electric vehicle technology, getting accustomed to the new driving experience by using hybrids. Since the hybrids also contain an internal combustion engine, drivers don’t have to worry about range or charging issues, something that prevents many drivers from making the switch.
In tests, T&E and other climate groups found that when the battery runs out of charge, the combustion engine has to work harder to move to propel the “dead weight” of the battery as well as charge it. This results in CO2 emissions that are three times higher than what is advertised.
Amanda Gibson, a spokeswoman from Mitsubishi, said that depending on the conditions, independent tests can produce unreliable or variable figures. A spokesman from Volvo noted that all cars manufactured by the firm are certified and comply fully with emissions regulations.
The EV sector could benefit significantly from working with payments-as-a-service entities on matters such as billing electric car owners for charging their vehicles. One interesting company in this niche is Net Element (NASDAQ: NETE), which focuses on offering financial technology solutions. The company is also in advanced stages of completing a merger with a California-based EV maker called Mullen Technologies Inc.
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will present at the Benzinga Global Small Cap Conference taking place virtually on Dec. 8-9, 2020. Genprex’s president and CEO, Rodney Varner, will deliver a company overview that includes recent progress the company has made on its upcoming Acclaim-1 clinical trial. Varner’s presentation is scheduled to begin at 2:30 p.m. EST on Tuesday, Dec. 8. Investors and other interested parties should visit https://ibn.fm/VdFrh to register for the event.
Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, “REQORSA(TM)” (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s web site atwww.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Energy Fuels has produced rare earth element (“REE”) concentrate on a pilot scale at wholly owned White Mesa Mill.
The high-purity concentrate is ready to send to separation plant for final acceptance test work.
Company used existing infrastructure and technologies, thereby avoiding years of permitting and development, as well as need for significant capital.
Energy Fuels (NYSE American: UUUU) (TSX: EFR) has produced a rare earth element (“REE”) carbonate concentrate on a pilot scale at its wholly owned White Mesa Mill, located in Utah (https://ibn.fm/WImVU). This may be the first REE concentrate produced from monazite sands at any significant quantity in North America in more than 20 years.
“Energy Fuels achieved a major milestone in U.S. rare earth element production when we successfully produced a REE Concentrate from a sample of monazite sands at our White Mesa Mill,” said Energy Fuels president and CEO Mark S. Chalmers. “Our company literally accomplished REE production in months, because we utilized existing resources, infrastructure and technologies. While it is still early days, and we still have a lot of work to do, this is a proud moment, not just for me, but for the entire Energy Fuels team who has diligently worked on making REE Concentrate production a reality.”
According to the company, the White Mesa Mill recovered the REEs, along with uranium, from one metric tonne of monazite sands. The concentrate is ready to send to a separation plant for final acceptance test work.
This milestone came relatively quickly, given that Energy Fuels just entered the REE space in April 2020. In just over six months, the company moved from laboratory-scale testing to producing pilot-scale REE Concentrate from a one tonne sample of monazite sands. The company possesses three tonnes of additional monazite sands samples, which it will use to further refine the process for recovering REEs and uranium from these types of ores.
The rapid progress made by Energy Fuels is reflective of its commitment to re-establish the ability of the U.S. to recover REEs and uranium from monazite sands using existing facilities and technologies. Additionally, as part of this commitment, the company is in negotiations to obtain additional sources of monazite sands for potential processing on a commercial scale at the Mill. Energy Fuels is also exploring the potential sale of REE Concentrate to a REE separation facility.
“By using existing infrastructure and technologies at the Mill to recover the uranium and the REEs from monazite sands, we are able to avoid the years of permitting and development, along with the tens, or even hundreds, of millions of dollars of capital that others would be faced with,” Chalmers said. “Assuming the company is able to secure adequate quantities of monazite sands, we expect to be in a position to produce commercial quantities of REE Concentrate by early 2021.
“Energy Fuels will always, first and foremost, be a uranium producer,” Chalmers continued. “We have been the number one uranium miner in the U.S. since 2017, a position we intend to keep for many years to come. However, when other complementary business opportunities arise with the potential to create significant cash flow utilizing our existing facilities and workforce, we will always take a hard look at them with an eye toward building shareholder value.
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
Canopy Rivers Inc. (” Canopy Rivers “) (TSX: RIV) (OTC: CNPOF) today provided an update on three portfolio companies.
“Over the past month, our portfolio companies have made several announcements that demonstrate their continued momentum and growth in their respective markets,” said Narbe Alexandrian. “We believe that this growth is a testament to the theses behind these investments, and we look forward to seeing their progress continue into 2021.”
TerrAscend Corp. (” TerrAscend “) announced that it received the final permit to dispense cannabis from its first medical dispensary in New Jersey . TerrAscend’s Apothecarium location in New Jersey opened to customers on November 24th . This opening follows TerrAscend’s third quarter results in which the company reported net sales of $51 million and adjusted EBITDA of $17.8 million .
YSS Corp. (” YSS “) announced its third quarter earnings . YSS reported that revenue increased 24% and gross margin grew by 31% compared to Q2 2020. It noted that its store-level EBITDA of approximately $0.6 million represented a 56% increase over the previous quarter. YSS added that its newest Calgary location is in the final phase of construction, and it is planning to open four additional stores, including two in Ontario .
Dynaleo Inc. (” Dynaleo “) received its sales licence from Health Canada. Dynaleo is now able to distribute gummies from its Edmonton -based manufacturing facility to provincial wholesalers and retailers. Dynaleo previously announced supply agreements with High12 Brands and California -based edibles company Pantry.
About Canopy Rivers
Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. We believe that bringing together people, capital, and ideas raises the potential of the entire cannabis industry. By leveraging our industry insights, in-house expertise, and thesis-driven approach to investing, we aim to provide shareholders with exposure to specialized and disruptive cannabis companies. Our mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with our portfolio, we are helping build the cannabis industry of tomorrow, today.
Forward Looking Statements
This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: the progress of portfolio companies continuing in 2021; the plan for YSS to open four additional locations, including two in Ontario ; and expectations for other economic, business, and/or competitive factors.
Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of Canopy Rivers. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; competition risks; changes in cannabis industry growth and trends; changes in the business activities, focus and plans of the Company and its investees; stock market volatility; changes in general economic, business and political conditions, including challenging global financial conditions and the impact of the novel coronavirus pandemic; potential conflicts of interest; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in Canopy Rivers’ relationship with its investees; counterparty risks, including risks associated with joint venture arrangements; risks associated with the termination, renegotiation and enforcement of material contracts; credit, liquidity and additional financing risks; changes in applicable laws; compliance with extensive government regulation, including Canopy Rivers’ interpretation of such regulation; changes in the global sentiment towards, and public opinion of, the cannabis industry; divestiture risks; and the risk factors set out in Canopy Rivers’ most recent annual information form and management’s discussion and analysis filed with the Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com .
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Thursday, December 3rd, 2020UncategorizedComments Off on $CNPOF Provides Update on TerrAscend, YSS, and Dynaleo
180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will participate in the LD Micro Virtual Main Event 2020 Conference. According to the update, 180 Life Sciences CEO Dr. James Woody is scheduled to present at 1:40 p.m. EST on Tuesday, Dec. 15. Interested parties should visit https://ibn.fm/KHrgf to register for the event. The 2020 LD Micro Main Event will feature a new and unique format with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts.
180 Life Sciences is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor), with its lead program in phase 2b/3 clinical trials. For more information about the company, visit www.180LifeSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at http://ibn.fm/ATNF
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
SRAX Inc.’s (NASDAQ: SRAX) Sequire Emerges as a Leader within Investor Intelligence Field
SRAX’s Sequire, an investor intelligence platform, seeks to combine investor intelligence services with detailed shareholder insights
Sequire boasts 91 publicly listed subscribers on its platform along with over 1 million investors and traders
Sequire’s platform allows companies to track their shareholders’ actions, interact with existing investors, meet with future prospective shareholders
Company is well-positioned to benefit from increased digitization of global investor relations functions
SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has rapidly emerged as a leader in the field of combining investor intelligence services with detailed shareholder insights. Launched as a stand-alone platform in early 2020, Sequire, SRAX’s SAAS investor intelligence platform, has garnered great popularity, having accrued over 1 million investors and traders. The company has also attracted over 91 publicly-listed companies as subscribers on its platform (https://ibn.fm/1Yunn) – an explosion of growth largely driven by Sequire’s extensive range of services.
Increasingly, companies have sought to adopt digital technology and the data generated from such mediums as a way of improving their engagement with customer and stakeholders alike. These insights have assisted companies in developing new products and services while also developing a better understanding of their consumer’s pain points and unmet needs (https://ibn.fm/YWtqe).
Sequire has seized upon this trend, harnessing the digital insights provided by the over 1 million investors currently on the company’s platform in a bid to help its corporate subscribers with their individual investor outreach programs. Sequire allows its subscribers to track their shareholders’ selling and buying trends, search and monitor key investors, track outstanding warrants, receive the latest company specific news and media and even create and send out customized shareholder surveys designed to bring forth their stake-holders’ insights and opinions (https://ibn.fm/C7geP).
The company’s management illustrated the platform’s potential by outlining one example, where a single corporate subscriber using Sequire has seen their number of individual shareholders skyrocket from 3,000 to over 360,000 during their tenure on the platform. The successes witnessed thus far have now led the Sequire SAAS platform to record six consecutive quarters of growth.
“The growth we experienced this last quarter and through today has been the fastest we have encountered as a public company,” said SRAX CEO and founder Christopher Miglino. “For the past six weeks we have closed close to $1M per week in business, mostly driven by our Sequire platform. Public issuers are seeing the benefits of the platform, and our data teams are gaining significant insights from that growth. Sequire now has over 1 million investors and traders, a significant portion of which are from the Robinhood platform.”
The business model underpinning corporate investor relations efforts has undergone a radical transformation in recent years, with digitization having now fully arrived in the field. IR websites and digital business reports are now standard, while the use of digital distribution channels for company communications becoming largely indispensable. However, the improvement in technology and greater bandwidth provided as a result has also led to new opportunities being created – webcasts and virtual events are allowing companies to communicate and interact with investors located in distant geographies while also providing a medium for investors to come into direct contact with corporate representatives.
Over time, big data and artificial intelligence are set to become ever more significant factors governing the development of the investor relations function – providing issuers with greater insights into their end investors while simultaneously allowing them to personalize their end interactions with the latter group (https://ibn.fm/8hptj). The recognition of these upcoming changes has underpinned the ongoing development of the Sequire platform, ideally placing it to benefit from the ongoing radical transformation of the global investor relations industry.
For more information, visit the company’s website at www.SRAX.com
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom athttp://ibn.fm/SRAX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Wordson all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced an expanded partnership with KeHE, which now includes the A88CBD(TM) topical products, A88 Infused(TM) flavors and the entire Alkaline88(R) line, including eco-friendly aluminum bottles. “KeHE has been an exceptional partner in our journey to become a national lifestyle brand,” said Ricky Wright, president and CEO of The Alkaline Water Company. “We are excited to announce that our premium quality, lab-tested A88CBD topical products will now be available to all KeHE accounts nationwide. Today, our flagship brand, Alkaline88, is being offered by thousands of KeHE customers, and the distributor has quickly become a top account for the company. This large and growing partner has been a key contributor to our five-year reported growth CAGR of over 60%. And over the last three years, we have done approximately $25 million in retail sales with their customers.”
Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies. To learn more about the company, visit www.A88CBD.com and www.TheAlkalineWaterCo.com.
NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently secured its first U.S. patent for its innovative Ultra Shear Technology (“UST”) platform. Utilizing ultra-high pressure and intense shearing forces, the platform creates unique, high-quality nanoemulsions that have enormous use in a wide variety of industries. Pressure BioSciences has received pre-orders for 12 BaroShear K45 systems, which it plans to deliver during the first half of 2021, and is also is in discussions with academic organizations and government agencies expressing interest in the platform for other product and research possibilities. These include an alternative for processing juices, fresh milk and other dairy products into long-term stable, room temperature, tasty products. “Nanoemulsions have long been shown to exhibit improved absorption, higher bioavailability and greater stability, while often requiring lower levels of emulsifiers than macro/micro emulsion products,” PBI’s Senior Vice President of Engineering Dr. Edmund Y. Ting stated in a recent update. “Because of these significant advantages, nanoemulsions are currently the focus of numerous research efforts worldwide. However, cost-effective scale-up of high quality nanoemulsion processing at a commercial level continues to be quite challenging. Importantly, we believe that PBI’s innovative and now patented UST platform can provide the key to commercial success for nanoemulsion products.”
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling pressure-based solutions for the worldwide life sciences and other industries. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Pressure BioSciences’ primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that its virtual Special Meeting of Stockholders, which was scheduled for Dec. 1, 2020, was held but no business was conducted because a full quorum was not in attendance. The meeting has been rescheduled for Dec. 30, 2020 at 3 p.m. CST. Arrangements have been made for stockholders can attend via a live audio webcast, allowing more opportunity for stockholders to vote on proposals outlined in the definitive proxy statement filed by Predictive Oncology with the Securities and Exchange Commission (“SEC”). The Special Meeting record date will remain Oct. 28, 2020. POAI management and board members encourage stockholder Stockholders of record to vote, regardless of whether they attend the meeting. Stockholders can vote in several ways: at the reconvened Special Meeting, by proxy using the proxy card included with POAI’s definitive proxy statement, or by proxy via facsimile, email or through the internet. Stockholders who have already voted need not take any action unless they want to change their vote.
Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. For more information about the company, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Net Element (NASDAQ: NETE) is transforming its business model to enter the electric vehicle (“EV”) industry through a reverse-merger with California-based Mullen Technologies Inc. The strategic move positions the company to benefit amid the dropping price of EV batteries, which has decreased 87% in less than a decade (https://ibn.fm/GRCa9) and is projected to drop even further due to technological innovations destined to make EVs a viable alternative to gas-powered vehicles. A recent article discussing this reads, “Mullen Technologies is already well on its way to making substantial progress on battery technology through subsidiary Mullen Energy. Along with Mullen Auto Sales, Mullen Finance Corp. and a digital marketplace called CarHub, Mullen is well-positioned to expand its footprint in the United States with plans to expand and construct new production facilities that will bring thousands of jobs to the country.”
Net Element operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. On Aug. 5, 2020, Net Element announced the execution of a definitive agreement to merge with privately-held Mullen Technologies Inc. (“Mullen”), a Southern California-based electric vehicle company in a stock-for-stock reverse merger in which Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger company (the “contemplated merger”). That contemplated merger is subject to customary closing conditions, regulatory approvals and shareholder approval for both companies. For additional information, visitwww.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Tesla recently illustrated the enthusiasm surrounding the EV sector by becoming the newest entrant to the S&P500 equity index
Investor interest in the sector has spilled over to Net Element, with one the world’s largest asset managers, Renaissance Technologies taking a 3.2% stake in the company in the third quarter
A future combined Net Element-Mullen Technologies plans to begin marketing its initial vehicle model, the Dragonfly K50 in 2Q2021.
Late in the day on November 16, Tesla (NASDAQ: TSLA) was named for inclusion in the S&P500 index, making it both the first electric vehicle manufacturer to form part of the group as well as the largest new entrant in the index’s history. Investors responded to the news headline by sending the stock up 8.2% the following day, leading Tesla’s market cap to swell by over $30 billion—a figure nearly equivalent to the entire market cap of consumer product giant Kraft Heinz. Net Element (NASDAQ: NETE), a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer after entering into a definitive agreement to merge with privately-held Mullen Technologies Inc., similarly profited from the market enthusiasm, rising by 25% over the course of the day.
The electric vehicle sector has benefitted from a sharp uptick in investor interest in recent months, as a combination of improving sector fundamentals have coupled with positive news-flow to drive sector returns. The most recent updates came from the United Kingdom, where the British government announced that the sale of new diesel and gasoline-powered vehicles would no longer be permitted from 2030 onwards – a date which has been shifted forward from its original target of 2040 (https://ibn.fm/OiZJy). Simultaneously, the government also announced its commitment to spending approximately $1.72 billion over the next four years towards improving electric vehicle (“EV”) charging infrastructure—a factor which has previously been highlighted by Deloitte as a key constraint to future growth in the sector (https://ibn.fm/OQaHg).
A potential combined Net Element-Mullen Technologies entity plans to leverage upon the surge in consumer demand within the electric vehicle space through the launch of its initial vehicle model – the Dragonfly K50—in the second quarter of 2021. The car model, developed in conjunction with China’s Qiantu Motors, will mark the company’s initial foray into the North American electric vehicle market, a venture which the company will further look to reinforce through the launch of its self-manufactured EV SUV, the Mullen MX-5, by the second quarter of 2022.
Mullen Technologies also revealed that it has recently signed a letter of intent with the City of Spokane to build a 1.5 million square foot facility to manufacture and assemble vehicles, with work on the facility set to commence later this year. Remarkably, the company also disclosed its expectation to arrive at production phase with as little as $400 million in invested capital over five years (as compared with the $1 billion traditionally required) due to its current vehicle IP, which has already been two years in the making.
By 2030, Deloitte anticipates that electric vehicle sales could rise to 31.1 million vehicles per annum, representing an over ten-fold increase to the 2.5 million electric vehicles set to be sold in 2020 – a shift which would lead the EV sector to secure a market share of 32 percent of total automotive sales within the next ten years. With interest in the sector at an all-time high – as evidenced by the United Kingdom’s policy announcement as well as the recent market returns evidenced by EV companies—Net Element finds itself in an ideal position to capitalize on one of the biggest shifts in consumer behavior the world has ever seen.
For more information, visit the company’s website at www.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
The mining industry as a whole has made great strides with regard to digitizing various mining site operations and processes. This offers mining firms many benefits, including the reduction of operation costs of the mine. These measures also optimize a mine’s major assets, allowing the goals and objectives of a mine to be predicted and monitored easily.
This progress also allows mines to keep track of their operating assets, ensuring that they remain undamaged. Digitization also allows mine operators to redistribute the water used in one process. This helps minimize effluent discharge volumes as well as the mine’s water intake. Overall, digitization helps save a mining firm about 30% in operational expenditures.
However, it seems this may not be all that’s needed to help firms in the industry better their safety and operational gains. Collaboration is said to be the next big thing. The combination of digital solutions and lean concepts may help improve the performance of firms in the mining industry through in-office collaborations.
A fine example of this would be a system based on data analysis that creates advanced maintenance schemes that help determine how mine assets should be maintained for optimal performance, when they should be maintained and what assets should be maintained.
Installing a state-of-the-art operating system that can improve a firm’s daily operations can also enhance a firm’s productivity and safety. To unlock digital transformation, firms in the mining industry may also need to work with partners that may not be involved in the same industry. This will broaden a company’s horizons, allowing a company to not only learn, grow and implement better measures but also bring partners on board that will join forces on solving mutual problems, often in a better and more effective way.
Teaming up with unlikely but formidable partners will also allow firms in the mining industry to understand similarities in areas such as automation and quantum technologies while allowing the firms in the natural resource sector to gain more insights on various issues.
With regard to new technologies, collaborating with technology companies may afford firms in the mining sector a competitive edge, which will allow them to develop and make use of new technologies. This will ensure that companies keep up with the changing times.
Productivity is one of the main objectives of mining firms. Precision mining will also change this, making the process better as well as sustainably and more economically possible, thus enabling more efficiency.
The mining sector has a few companies that stand out in the different segments of this industry. For example, Energy Fuels Inc. (TSX: EFR) (NYSE American: UUUU) is the top U.S. producer of vanadium and uranium.
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
A research study conducted by Centre for Prevention of Stroke and Dementia clinical research fellow Dr. Karolina Wartolowska investigated the presence of white matter hyperintensities in the brain. These hyperintensities usually highlight small blood vessels that may be damaged and that manifest on MRI scans as bright regions. This damage is said to increase with blood pressure and age; the damage is linked to a decrease in cognitive function and an increased risk of depression, physical disabilities, dementia and stroke.
The study involved 37,041 individuals enrolled in the UK Biobank. A huge chunk of the participants was recruited from the general population and were aged between 40–69. The availability of medical information, e.g., MRI brain scans, was also a factor. The study findings show that there was a strong link between brain damage past the age of 50 and the diastolic blood pressure before people hit age 50. This applies even when the diastolic blood pressure is within a healthy range.
Wartolowska explains that while these changes do not occur in all aging individuals, many people who are older than 80 years and may not have high blood pressure as well as more than 50% of individuals over age 65 are still at risk. The intensities are, however, more likely to develop if an individual has high blood pressure, at which point, they become severe.
The participants’ information had been collected previously between March 2006 and October 2010 when the individuals registered in the UK Biobank. Other data, inclusive of the scans, was acquired between August 2014 and October 2019. The information used in the study had been adjusted by the researchers, taking into consideration the individual’s systolic and diastolic blood pressure, sex and age, as well as risk factors such as diabetes and smoking.
The researchers then analyzed the white matter intensities (WMH) load in all individuals and found that a bigger WMH load was linked to previous diastolic blood pressure, especially for participants under age 50. Any increase in blood pressure was connected to an increase in the white matter intensities, particularly for individuals who were taking medication for high blood pressure.
The researchers also discovered that the diastolic blood pressure of individuals in their 40s and 50s was linked to considerable brain damage later in life. This makes diastolic blood pressure, as well as systolic blood pressure, an important factor in the prevention of brain-tissue damage. Wartolowska adds that while many individuals think that stroke and hypertension are old-people diseases, research shows that if individuals would like to keep their brains healthy into their 70s, they may need to ensure that their blood pressure, inclusive of one’s diastolic blood pressure, remains in a healthy range when they are in their 40s and 50s.
Speaking of high blood pressure, a number of biotech companies have devoted their efforts toward helping patients with chronic noncommunicable diseases, such as hypertension. An example is DarioHealth Corp. (NASDAQ: DRIO), which is famous for its smartphone-based, customized, chronic disease-management software that helps patients make lasting changes to their lifestyle.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer